309 related articles for article (PubMed ID: 23190500)
21. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.
Erkek S; Johann PD; Finetti MA; Drosos Y; Chou HC; Zapatka M; Sturm D; Jones DTW; Korshunov A; Rhyzova M; Wolf S; Mallm JP; Beck K; Witt O; Kulozik AE; Frühwald MC; Northcott PA; Korbel JO; Lichter P; Eils R; Gajjar A; Roberts CWM; Williamson D; Hasselblatt M; Chavez L; Pfister SM; Kool M
Cancer Cell; 2019 Jan; 35(1):95-110.e8. PubMed ID: 30595504
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
25. SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors.
Kim SS; Moghe M; Rait A; Donaldson K; Harford JB; Chang EH
Int J Nanomedicine; 2024; 19():5973-5993. PubMed ID: 38895149
[TBL] [Abstract][Full Text] [Related]
26. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.
Knutson SK; Warholic NM; Wigle TJ; Klaus CR; Allain CJ; Raimondi A; Porter Scott M; Chesworth R; Moyer MP; Copeland RA; Richon VM; Pollock RM; Kuntz KW; Keilhack H
Proc Natl Acad Sci U S A; 2013 May; 110(19):7922-7. PubMed ID: 23620515
[TBL] [Abstract][Full Text] [Related]
27. EZH2 is essential for glioblastoma cancer stem cell maintenance.
Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer.
Wu C; Jin X; Yang J; Yang Y; He Y; Ding L; Pan Y; Chen S; Jiang J; Huang H
Oncotarget; 2016 Jan; 7(3):3440-52. PubMed ID: 26657505
[TBL] [Abstract][Full Text] [Related]
29. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer.
Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets.
Sredni ST; Bonaldo Mde F; Costa FF; Huang CC; Hamm CA; Rajaram V; Tomita T; Goldman S; Bischof JM; Soares MB
Childs Nerv Syst; 2010 Mar; 26(3):279-83. PubMed ID: 20012062
[TBL] [Abstract][Full Text] [Related]
31. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.
Zin F; Cotter JA; Haberler C; Dottermusch M; Neumann J; Schüller U; Schweizer L; Thomas C; Nemes K; Johann PD; Kool M; Frühwald MC; Paulus W; Judkins A; Hasselblatt M
Brain Pathol; 2021 Sep; 31(5):e12967. PubMed ID: 33938067
[TBL] [Abstract][Full Text] [Related]
32. Targeting of cyclin-dependent kinases in atypical teratoid rhabdoid tumors with multikinase inhibitor TG02.
Ding AS; Huq S; Casaos J; Raj D; Morales M; Zhao T; Kim T; Srivastava S; Pant A; Serra R; Gorelick NL; Brem H; Tyler B
J Neurosurg Pediatr; 2021 Sep; 28(6):734-743. PubMed ID: 34479190
[TBL] [Abstract][Full Text] [Related]
33. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
[TBL] [Abstract][Full Text] [Related]
35. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
[TBL] [Abstract][Full Text] [Related]
37. EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation.
Hubaux R; Thu KL; Coe BP; MacAulay C; Lam S; Lam WL
J Thorac Oncol; 2013 Aug; 8(8):1102-6. PubMed ID: 23857401
[TBL] [Abstract][Full Text] [Related]
38. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
Pacheco MC; Dolan M; Bendel A
Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.
Unland R; Borchardt C; Clemens D; Kool M; Dirksen U; Frühwald MC
Anticancer Drugs; 2015 Mar; 26(3):301-11. PubMed ID: 25415657
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
